115 results on '"Gill, John"'
Search Results
2. The Benefits of Preemptive Transplantation Using High–Kidney Donor Profile Index Kidneys
3. Range and Consistency of Cardiovascular Outcomes Reported by Clinical Trials in Kidney Transplant Recipients: A Systematic Review
4. Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation
5. A Phase 1b, Multicenter, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Tegoprubart (AT-1501) in Patients Undergoing Kidney Transplant: PUB299
6. 413.3: Towards a National System of Living Donor Follow-up in Canada
7. 400.4: Deceased Kidney Donor Acceptance Criteria: A Survey of Canadian Transplant Nephrologists, Surgeons and Urologists
8. Immunosuppressant Medication Use in Patients with Kidney Allograft Failure: A Prospective Multicenter Canadian Cohort Study
9. Case Report: Absence of Clinically Significant Recurrent Diabetic Kidney Disease on Postmortem Biopsy 32 Years After Kidney Transplantation for Type 1 Diabetes
10. The Orthopaedic Political Action Committee: Growth and Influence Over 20 Years
11. Trends in cause-specific mortality in HIV-Hepatitis C co-infection following hepatitis C treatment scale-up
12. Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive Individuals
13. Determinants of Liver Complications Among HIV/Hepatitis B Virus–Coinfected Patients
14. Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1–Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy
15. A Promising Therapy in Jeopardy: The Need to Define Limits for Extracorporeal Cardiopulmonary Resuscitation
16. Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio
17. Cause for Cautious Optimism: Belatacept for Patients With Impaired Kidney Allograft Function
18. Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion
19. Cancer burden attributable to cigarette smoking among HIV-infected people in North America
20. Antiretroviral pill count and clinical outcomes in treatment‐naïve patients with HIV infection
21. Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort
22. Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions
23. Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study
24. HIV incidence in the Estonian population in 2013 determined using the HIV‐1 limiting antigen avidity assay
25. The outstanding questions in transplantation: Itʼs about time…
26. Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America
27. HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy—Results From the IeDEA Collaboration
28. Expectations and Experiences of Follow-up and Self-Care After Living Kidney Donation: A Focus Group Study
29. CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus
30. Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients
31. SYNTHETIC BIOLOGY: Design and synthesis of a minimal bacterial genome
32. The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV Patients
33. Substance P Regulates Puberty Onset and Fertility in the Female Mouse
34. The Canadian Kidney Paired Donation Program: A National Program to Increase Living Donor Transplantation
35. BK Virus Prophylaxis With Levofloxacin—Reply
36. Implementing an Intimate Partner Violence (IPV) Screening Protocol in HIV Care
37. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America
38. Gestational Hypertension and Preeclampsia in Living Kidney Donors
39. Levofloxacin for BK Virus Prophylaxis Following Kidney Transplantation: A Randomized Clinical Trial
40. Mortality in HIV–hepatitis C co-infected patients in Canada compared to the general Canadian population (2003–2013)
41. Outcomes After Kidney Donation—Reply
42. Spinal cord stimulation is safe and feasible in patients with advanced heart failure: early clinical experience
43. Correlation of intracardiac electrogram with surface electrocardiogram in Brugada syndrome patients
44. Understanding Rare Adverse Outcomes Following Living Kidney Donation
45. Living kidney donor estimated glomerular filtration rate and recipient graft survival
46. Central Precocious Puberty Caused by Mutations in the Imprinted Gene MKRN3
47. Increased Neurokinin B (Tac2) Expression in the Mouse Arcuate Nucleus Is an Early Marker of Pubertal Onset with Differential Sensitivity to Sex Steroid-Negative Feedback than Kiss1
48. Guillain–Barré Syndrome
49. Acute dialysis risk in living kidney donors
50. Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.